Just a moment...

Top
Help
×

By creating an account you can:

Logo TaxTMI
Call Us / Help / Feedback

Contact Us At :

E-mail: [email protected]

Call / WhatsApp at: +91 99117 96707

For more information, Check Contact Us

FAQs :

To know Frequently Asked Questions, Check FAQs

Most Asked Video Tutorials :

For more tutorials, Check Video Tutorials

Submit Feedback/Suggestion :

Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters0/2000
Add to...
You have not created any category. Kindly create one to bookmark this item!
Create New Category
Hide
Title :
Description :
❮❮ Hide
Default View
Expand ❯❯
Close ✕
🔎 Newsletters - Adv. Search
Year:
---- All Years ----
  • ---- All Years ----
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
Month:
---- All Months ----
  • ---- All Months ----
  • January
  • February
  • March
  • April
  • May
  • June
  • July
  • August
  • September
  • October
  • November
  • December
❯❯
MaximizeMaximizeMaximize
0 / 200
Expand Note
Add to Folder

No Folders have been created

    +

    Are you sure you want to delete "My most important" ?

    NOTE:

    Daily Newsletters
    Showing Results for :
    Reset Filters
    Results Found:
    Show All SummariesHide All Summaries

    Daily Newsletter

    Back

    All Daily Newsletter

    Showing Results for :
    Reset Filters
      No Records Found

      Daily Newsletter

      Back

      All Daily Newsletter

      whatsappJoin Channel
      Showing Results for : Reset Filters

      TaxTMI Updates e-Newsletter
      Jun 13,2016

      Contents
      Note

      Note

      -

      Bookmark

      Print

      Print

      Collapse
      18 Highlights Toggle
      2 Articles Toggle
      By: DR.MARIAPPAN GOVINDARAJAN
      Summary: The document emphasises a liberalised FDI regime allowing full foreign equity in pharmaceutical manufacturing (Greenfield and Brownfield subject to Brownfield conditions), accompanied by certification requirements disallowing non compete clauses in inter se agreements; it highlights government incentives (tax breaks, weighted R&D deductions, venture funds, biotech parks), regulatory oversight by central drug authorities and the NPPA for pricing control, and the shift to product patents post 2005, all of which shape investment, R&D strategy and compliance obligations in the industry.
      By: Bimal jain
      Summary: Senior advocates' representational legal services to business entities located in the taxable territory are brought under reverse charge, making the business entity litigant, applicant or petitioner the recipient liable to pay service tax; exemptions remain for supplies to non-business entities and to business entities below a stated turnover threshold, and the Reverse Charge Notification prescribes full (100%) recipient liability.
      1 News Toggle
      Summary: Stock-taking review of the Trade & Economic Partnership Agreement negotiations noted that thirteen rounds of Chief Negotiator-level talks since 2008 had been suspended after 2013; both sides agreed to jointly address outstanding substantive issues and to resume negotiations promptly to conclude a balanced agreement in a time-bound manner.
      1 Notifications Toggle

      Income Tax

      1.
      9/2016 - dated - 9-6-2016 - Inc.Tax Act 1961
      Simplification of procedure for Form No. 15G & 15H - Clarifications
      Summary: The notification clarifies that under Section 197A and Rule 29C payers must follow prescribed formats, verification standards and unique identification procedures for Form 15G/15H, and it sets quarterly due dates for uploading declarations to the government e filing portal; a transitional requirement mandates uploading declarations received in the interim period by the single specified compliance deadline using the prescribed format and portal.
      1 Circulars Toggle

      Customs

      1.
      27/2016 - dated 10-6-2016
      Procedure to be followed by nominated agencies importing gold/silver/platinum under the scheme for ‘Export Against Supply by Nominated Agencies’
      Summary: Nominated agencies supplying duty free gold, silver and platinum must clear exempted imports on a bill of entry for home consumption and not under warehousing; transitional storage in existing licensed vaults is allowed. Agencies must execute bonds to maintain accounts and to cover duty liability if exporters fail to meet export obligations, and must furnish a bank guarantee with limited exemptions for designated banks and certain public sector undertakings. Exporters/EOUs must register or self declare, supply proof of export within the Foreign Trade Policy period, and nominated agencies must file monthly exporter wise accounts and deposit duty where export proof is not produced.
      32 Case Laws Toggle
      AI TextQuick Glance by AIHeadnote

      Topics

      ActsIncome Tax